California Nanotechnologies (FRA:R14) Beneish M-Score: 2.48 (As of Jun. 28, 2026)


FRA:R14 California Nanotechnologies Corp FRA:R14
40 GF Score
Price €0.14
GF Value €0.18
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is California Nanotechnologies Beneish M-Score?

California Nanotechnologies FRA:R14 -11.39% 40 Beneish M-Score is 2.48 as of Jun. 28, 2026. GuruFocus rates FRA:R14 with a GF Score™ of 40/100 and a GF Value™ of €0.18 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,526 Chemicals companies, California Nanotechnologies ranks worse than 97.64% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 2.48 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for California Nanotechnologies's Beneish M-Score or its related term are showing as below:

FRA:R14' s Beneish M-Score Range Over the Past 10 Years
Min: -5.81   Med: -2.71   Max: 6.86
Current: 2.48

During the past 13 years, the highest Beneish M-Score of California Nanotechnologies was 6.86. The lowest was -5.81. And the median was -2.71.


California Nanotechnologies Beneish M-Score Historical Data

* Premium members only.

The historical data trend for California Nanotechnologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

California Nanotechnologies Beneish M-Score Chart

California Nanotechnologies Annual Data
Trend Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.81 2.27 -5.19 -0.44 0.59

California Nanotechnologies Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.54 0.59 -1.13 1.55 2.48

FRA:R14 vs LIN, SHW, ECL: Beneish M-Score Comparison

For the Specialty Chemicals subindustry, California Nanotechnologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


California Nanotechnologies Beneish M-Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, California Nanotechnologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where California Nanotechnologies's Beneish M-Score falls into.


FRA:R14
40GF Score
California Nanotechnologies Corp FRA:R14
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

California Nanotechnologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of California Nanotechnologies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8348+0.528 * 1.2866+0.404 * 19.8548+0.892 * 0.4897+0.115 * 0.504
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 2.6168+4.679 * -0.57784-0.327 * 0.6925
=1.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Nov25) TTM:Last Year (Nov24) TTM:
Total Receivables was €0.47 Mil.
Revenue was 0.339 + 0.67 + 0.636 + 1.102 = €2.75 Mil.
Gross Profit was 0.054 + 0.415 + 0.362 + 0.764 = €1.60 Mil.
Total Current Assets was €0.80 Mil.
Total Assets was €3.57 Mil.
Property, Plant and Equipment(Net PPE) was €2.73 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.64 Mil.
Selling, General, & Admin. Expense(SGA) was €2.13 Mil.
Total Current Liabilities was €0.79 Mil.
Long-Term Debt & Capital Lease Obligation was €0.93 Mil.
Net Income was -0.947 + -0.251 + -0.397 + -0.3 = €-1.90 Mil.
Non Operating Income was -0.202 + 0.079 + 0.002 + 0.255 = €0.13 Mil.
Cash Flow from Operations was -0.144 + -0.251 + 0.064 + 0.362 = €0.03 Mil.
Total Receivables was €1.14 Mil.
Revenue was 1.701 + 1.38 + 1.618 + 0.911 = €5.61 Mil.
Gross Profit was 1.311 + 1.137 + 1.064 + 0.679 = €4.19 Mil.
Total Current Assets was €1.71 Mil.
Total Assets was €5.44 Mil.
Property, Plant and Equipment(Net PPE) was €3.73 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.39 Mil.
Selling, General, & Admin. Expense(SGA) was €1.66 Mil.
Total Current Liabilities was €2.17 Mil.
Long-Term Debt & Capital Lease Obligation was €1.61 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.466 / 2.747) / (1.14 / 5.61)
=0.16964 / 0.203209
=0.8348

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4.191 / 5.61) / (1.595 / 2.747)
=0.747059 / 0.580633
=1.2866

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (0.799 + 2.727) / 3.565) / (1 - (1.713 + 3.725) / 5.441)
=0.01094 / 0.000551
=19.8548

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2.747 / 5.61
=0.4897

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.393 / (0.393 + 3.725)) / (0.637 / (0.637 + 2.727))
=0.095435 / 0.189358
=0.504

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2.127 / 2.747) / (1.66 / 5.61)
=0.774299 / 0.2959
=2.6168

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.929 + 0.787) / 3.565) / ((1.614 + 2.168) / 5.441)
=0.481346 / 0.695093
=0.6925

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1.895 - 0.134 - 0.031) / 3.565
=-0.57784

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

California Nanotechnologies has a M-score of 1.74 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 2.48 mean?
California Nanotechnologies (FRA:R14) has a Beneish M-Score of 2.48 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on California Nanotechnologies and its competitors. According to the industry distribution chart, California Nanotechnologies ranks #1490 out of 1526 companies in the Chemicals industry, placing it in the top 97.6%.
Is California Nanotechnologies' Beneish M-Score too high?
California Nanotechnologies' current Beneish M-Score is 2.48. Based on the distribution chart, California Nanotechnologies ranks #1490 out of 1526 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, California Nanotechnologies has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does California Nanotechnologies' Beneish M-Score compare to LIN and SHW?
According to the Chemicals industry distribution chart, California Nanotechnologies ranks #1490 out of 1526 companies for Beneish M-Score. This places California Nanotechnologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Chemicals company?
A good Beneish M-Score depends on the Chemicals industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on California Nanotechnologies and its competitors. California Nanotechnologies's current Beneish M-Score is 2.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is California Nanotechnologies stock overvalued right now?
Based on GuruFocus' analysis, California Nanotechnologies (FRA:R14) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.18, compared to a current price of €0.14 — trading 22.2% below its estimated fair value. The current Beneish M-Score is 2.48. California Nanotechnologies' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For California Nanotechnologies (FRA:R14), the current Beneish M-Score is 2.48 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is California Nanotechnologies (FRA:R14) Overvalued in 2026?

Based on GuruFocus' analysis, California Nanotechnologies stock appears to be undervalued. The current stock price of €0.14 is trading 22.2% below its estimated GF Value™ of €0.18. GuruFocus considers California Nanotechnologies to be Modestly Undervalued.

Key valuation signals for FRA:R14:

  • Beneish M-Score: 2.48
  • GF Value™: €0.18 vs. price of €0.14 (22.2% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the FRA:R14 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


California Nanotechnologies Business Description

Other Exchanges CANOF:USACNO:Canada
Address 110 Yonge Street, Suite 1601, Toronto, ON, CAN, M5C 1T4
California Nanotechnologies Corp engages in the production, and research and development of nanostructured components and materials. Its products include High-Strength Graphite Spark tooling, Plasma Sintering Tooling, Tungsten Carbide Tooling, Carbon Graphite Foil, Carbon Felt and Yarn, and others.
40GF Score

Get the complete analysis for FRA:R14

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price
€0.18
GF Value